CRISPR Medicine News
Business News
About CRISPR Medicine News
Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Transthyretin Amyloidosis with Polyneuropathy, ATTRv-PN, (NCT06672237)
Sponsors:
Intellia Therapeutics
Sponsors:
Intellia Therapeutics
IND Enabling
Phase I
Phase II
Phase III